SEARCH RESULTS FOR:

Peih Yoke Hoo

MANAGING DIRECTOR, LINDE (MALAYSIA)
"Supply reliability is the priority of our customers. A minute of downtime could result in losses of millions of dollars."

Roger Erickson

CEO AND FOUNDER, INTERBIOME
"We want to pioneer a commodity utility approach for needed areas of pharmaceutical manufacturing, and make that available as a sustainable platform that any country can start with and innovate from."

Jan Kengelbach

CEO, AENOVA GROUP
"Experienced CDMOs can provide companies with access to new formulation and technology methods that improve the bioavailability of difficult-to-formulate compounds."

Donna LaVoie

PRESIDENT AND CEO, LAVOIEHEALTHSCIENCE
"Companies should be ready to address hostile short-selling and unsolicited takeover bids, develop rapid responses to special meetings and activist demands, and vigorously engage with institutional shareholders, proxy advisory firms, and potential regulators."

Daniel Prince

CEO, PRINCE STERILIZATION SERVICES
"The expansion will allow Prince to more than double its headcount, increase manufacturing capacity, and offer additional ready-to-use products and sterilization services to the market."

Tom Larsen & Bill Pearson

CEO (TL) & EXECUTIVE VICE PRESIDENT OF EXPLORATION (BP), ELORO RESOURCES
"We have a remarkable opportunity at our Iska Iska asset in Bolivia to outline two world-class deposits."

Emily Thorn Corthay

FOUNDER AND CEO, THORN ASSOCIATES
"Today, most major and mid-tier mining companies have targets, and are working a plan to move it forward, but the targets are still not ambitious enough, and the industry needs to accelerate and do more, faster."

Eduardo Cossio Chirinos

CEO, INCIMMET
"Nuestro avance tecnológico más maduro es un dron equipado con una cámara técnica y un sofisticado algoritmo impulsado por inteligencia artificial. Gracias a nuestro progreso, podemos prever el desprendimiento de rocas, que representa la causa principal de accidentes fatales en minería subterránea."

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.

Aloke Lohia

FOUNDER AND GROUP CEO, INDORAMA VENTURES PUBLIC COMPANY LIMITED (IVL)
"Despite being the largest PET producer globally, Indorama Ventures only captures about 1% of a very fragmented market, which is worth about US$2 trillion. There is plenty of room for growth."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

MACIG 2025 - Mining in Africa Country Investment Guide

It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.

PARTNER EVENTS